Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario

References

• Dyar OJ, Huttner B, Schouten J, et al. What is antimicrobial stewardship? Clin Microbiol Infect. 2017 Nov;23(11):793–798.
   PubMed Web of Science ®Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: Guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016 May 15;62(10):e51–77.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Bassetti M. Too many antibiotics for patients with COVID-19 despite low bacterial infections. Lancet Infect Dis. 2023 Jan 27;23(6):636–637.
   PubMed Web of Science ®Google Scholar
• Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020 Dec 3;71(9):2459–2468. doi: 10.1093/cid/ciaa530
   PubMed Web of Science ®Google Scholar
• Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020 Aug;81(2):266–275. doi: 10.1016/j.jinf.2020.05.046
   PubMed Web of Science ®Google Scholar
• Alshaikh FS, Godman B, Sindi ON, et al. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis. PLoS One. 2022;17(8):e0272375. doi: 10.1371/journal.pone.0272375
   PubMed Web of Science ®Google Scholar
• De Waele JJ, Derde L, Bassetti M. Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s? Intensive care Med. 2021 Jan;47(1):104–106. doi: 10.1007/s00134-020-06278-x
   PubMed Web of Science ®Google Scholar
• Liu Q, Qin C, Liu M, et al. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty. 2021 Nov 14;10(1):132.
   PubMed Web of Science ®Google Scholar
• Hilty MP, Keiser S, Wendel Garcia PD, et al. mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland. Intensive care Med. 2022 Mar;48(3):362–365.
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zanella A, Carlesso E, et al. Association of COVID-19 vaccinations with intensive care unit admissions and outcome of critically Ill patients with COVID-19 pneumonia in Lombardy, Italy. JAMA Netw Open. 2022 Oct 3;5(10):e2238871.
   PubMed Web of Science ®Google Scholar
• Mikulska M, Sepulcri C, Dentone C, et al. Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients. Clin Infect Dis. 2023 Mar 28. doi: 10.1093/cid/ciad181
   Web of Science ®Google Scholar
• Wai AK, Chan CY, Cheung AW, et al. Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19. Lancet Reg Health West Pac. 2023 Jan;30:100602.
   PubMedGoogle Scholar
• Bassetti M, Giacobbe DR, Aliberti S, et al. Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect. 2020 Jul;26(7):880–894.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Gutierrez B, Del Toro MD, Borobia AM, et al. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect Dis. 2021 Jun;21(6):783–792.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Di Maria E, Tagliafico AS, et al. External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact. Ann Med. 2023 Dec;55(1):2195204.
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020 Apr 11;395(10231):1225–1228.
   PubMed Web of Science ®Google Scholar
• Chan YK, Wong RY, Ip M, et al. Economic outcomes of influenza in hospitalized elderly with and without ICU admission. Antivir Ther. 2017;22(2):173–177. doi: 10.3851/IMP3102
   PubMed Web of Science ®Google Scholar
• Qin X, Wu S, Hao M, et al. The colonization of carbapenem-resistant Klebsiella pneumoniae: Epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020 Mar 16;221(Suppl 2):S206–S214.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Zhang XB, Hu L, Ming Q, et al. Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: A retrospective analysis. PLoS One. 2021;16(1):e0246030. doi: 10.1371/journal.pone.0246030
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934–943.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Z. Identification of risk factors for in-hospital death of COVID-19 pneumonia – lessions from the early outbreak. BMC Infect Dis. 2021 Jan 25;21(1):113.
   PubMed Web of Science ®Google Scholar
• Vena A, Giacobbe DR, Di Biagio A, et al. Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy. Clin Microbiol Infect. 2020 Nov;26(11):1537–1544.
   PubMed Web of Science ®Google Scholar
• Merugu GP, Nesheiwat Z, Balla M, et al. Predictors of mortality in 217 COVID-19 patients in Northwest Ohio, United States: A retrospective study. J Med Virol. 2021 May;93(5):2875–2882.
   PubMed Web of Science ®Google Scholar
• Marcolino MS, Ziegelmann PK, Souza-Silva MVR, et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry. Int J Infect Dis. 2021 Jun;107:300–310.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Abejon E, Tamayo E, Martin-Garcia D, et al. Clinical profile, treatment and predictors during the first COVID-19 Wave: A population-based registry analysis from castile and Leon hospitals. Int J Environ Res Public Health. 2020 Dec 14;17(24):9360.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020 Jun 5;133(11):1261–1267.
   PubMed Web of Science ®Google Scholar
• Cui N, Yan R, Qin C, et al. Clinical characteristics and immune responses of 137 deceased patients with COVID-19: A retrospective study. Front Cell Infect Microbiol. 2020;10:595333. doi: 10.3389/fcimb.2020.595333
   PubMed Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26;368:m1091.
   PubMed Web of Science ®Google Scholar
• Cao J, Tu WJ, Cheng W, et al. Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Jul 28;71(15):748–755.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Giacobbe DR, Bruzzi P, et al. Clinical management of adult patients with COVID-19 outside intensive care units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Infect Dis Ther. 2021 Dec;10(4):1837–1885.
   PubMed Web of Science ®Google Scholar
• Villanueva-Lozano H, Trevino-Rangel RJ, Gonzalez GM, et al. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect. 2021 Jan 8;27(5):813–816.
   PubMed Web of Science ®Google Scholar
• Vaseghi N, Sharifisooraki J, Khodadadi H, et al. Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): A systematic review and meta-analysis. Mycoses. 2022 Jul;65(7):683–703.
   PubMed Web of Science ®Google Scholar
• Rajni E, Singh A, Tarai B, et al. A high frequency of candida auris blood stream infections in coronavirus disease 2019 patients admitted to intensive care units, Northwestern India: A case control study. Open Forum Infect Dis. 2021 Dec;8(12):ofab452.
   PubMed Web of Science ®Google Scholar
• Prestel C, Anderson E, Forsberg K, et al. Candida auris outbreak in a COVID-19 specialty care unit - Florida, July-August 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):56–57.
   PubMed Web of Science ®Google Scholar
• Najeeb H, Siddiqui SA, Anas Z, et al. The menace of candida auris epidemic amidst the COVID-19 pandemic: A systematic review. Diseases. 2022 Aug 29;10(3):58.
   PubMedGoogle Scholar
• Moin S, Farooqi J, Rattani S, et al. C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan. Med Mycol. 2021 Dec 3;59(12):1238–1242.
   PubMed Web of Science ®Google Scholar
• Magnasco L, Mikulska M, Giacobbe DR, et al. Spread of carbapenem-resistant gram-negatives and candida auris during the COVID-19 pandemic in critically Ill patients: One step back in antimicrobial stewardship? Microorganisms. 2021 Jan 3;9(1):95.
   PubMed Web of Science ®Google Scholar
• Katsiari M, Mavroidi A, Kesesidis N, et al. Emergence of clonally-related South Asian Clade I Clinical Isolates of Candida auris in a Greek COVID-19 intensive care unit. Journal Of Fungi (Basel, Switzerland). 2023 Feb 11;9(2):243.
   PubMedGoogle Scholar
• Janniger EJ, Kapila R. Public health issues with Candida auris in COVID-19 patients. World Med Health Policy. 2021 Dec;13(4):766–772. doi: 10.1002/wmh3.472
   PubMedGoogle Scholar
• Hinrichs C, Wiese-Posselt M, Graf B, et al. Successful control of Candida auris transmission in a German COVID-19 intensive care unit. Mycoses. 2022 Jun;65(6):643–649.
   PubMed Web of Science ®Google Scholar
• Di Pilato V, Codda G, Ball L, et al. Molecular epidemiological investigation of a Nosocomial Cluster of C. auris: Evidence of recent emergence in Italy and ease of transmission during the COVID-19 pandemic. J Fungi (Basel). 2021 Feb 15;7(2):140.
   PubMedGoogle Scholar
• de Almeida JN, Francisco EC, Hagen F, et al. Emergence of Candida auris in Brazil in a COVID-19 intensive care unit. Journal Of Fungi (Basel, Switzerland). 2021 Mar 17;7(3):220.
   PubMedGoogle Scholar
• Codda G, Willison E, Magnasco L, et al. In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022. Euro Surveill. 2023 Apr;28(14). doi: 10.2807/1560-7917.ES.2023.28.14.2300161
   PubMedGoogle Scholar
• Ben Abid F, Salah H, Sundararaju S, et al. Molecular characterization of Candida auris outbreak isolates in Qatar from COVID-19 patients reveals the emergence of isolates resistant to three classes of antifungal drugs. Clin Microbiol Infect. 2023 Apr 26. doi: 10.1016/j.cmi.2023.04.025
   PubMed Web of Science ®Google Scholar
• Allaw F, Haddad SF, Habib N, et al. COVID-19 and C. auris: A case-control study from a tertiary care center in lebanon. Microorganisms. 2022 May 11;10(5):1011.
   PubMed Web of Science ®Google Scholar
• Briano F, Magnasco L, Sepulcri C, et al. Candida auris candidemia in critically Ill, colonized patients: Cumulative incidence and risk factors. Infect Dis Ther. 2022 Jun;11(3):1149–1160.
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99–111.
   PubMed Web of Science ®Google Scholar
• Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med. 2021 Jun 10;384(23):2187–2201.
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 Feb 4;384(5):403–416.
   PubMed Web of Science ®Google Scholar
• Motos A, Lopez-Gavin A, Riera J, et al. Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study. Eur Respir J. 2022 Feb;59(2):2102275.
   PubMed Web of Science ®Google Scholar
• Chen JZ, Hoang HL, Yaskina M, et al. Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial. Lancet Infect Dis. 2023 Jan 27;23(6):673–682. doi: 10.1016/S1473-3099(22)00832-5
   PubMed Web of Science ®Google Scholar
• Maataoui N, Chemali L, Patrier J, et al. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2227–2234.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Crea F, Morici P, et al. T2bacteria and T2Resistance assays in critically Ill patients with sepsis or septic shock: A descriptive experience. Antibiotics (Basel). 2022 Dec 15;11(12):1823.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Giani T, Bassetti M, et al. Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications. Clin Microbiol Infect. 2020 Jun;26(6):713–722.
   PubMed Web of Science ®Google Scholar